Riluzole Orodispersible Film Replicate Bioavailability
NCT04819438
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Participants
Interventions
DRUG:
Riluzole 50 mg orodispersible film
DRUG:
Rilutek® 50 mg riluzole tablets
Sponsor
Cross Research S.A.
Collaborators
[object Object]